Invesaro

Stocks Technology BKYI

NASDAQ · Technology

Bio Key International Inc (BKYI)

Bio Key International Inc brought in $6.7M of revenue over the twelve months to June 30, 2026, down 3.1% from a year earlier. It posted a net loss of $6M. In fiscal 2025 capital spending exceeded operating cash flow by $4.7M. At June 30, 2026 it held $1.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Free, no password. An email when BKYI files with the SEC.

Price
$2.48
+5.09% on the day · November 11, 2026
52-week range $1.55 to $11.10
Market cap
$3.6M
Revenue (last 12 months)
$6.7M
-3.1% year on year
Net margin
-90.1%

Key facts about Bio Key International Inc

Net worth
Bio Key International Inc has a market value (market cap) of $3.6M at the latest share price, and shareholders' equity of $4.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $5.9M (-14.3% year on year), with a net loss of $7.2M. Over the 12 months to June 30, 2026: revenue $6.7M, net loss $6M.
Cash flow
In fiscal 2025 operations used $4.7M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

What Bio Key International Inc does

Bio Key International Inc is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NASDAQ under the ticker BKYI.

Revenue and profit by year

Revenue
FY18: $4M $4M FY18FY19: $2.3M $2.3M FY19FY20: $2.8M $2.8M FY20FY21: $5.1M $5.1M FY21FY22: $7M $7M FY22FY23: $7.8M $7.8M FY23FY24: $6.9M $6.9M FY24FY25: $5.9M $5.9M FY25
Net income
FY18: -$6.9M -$6.9M FY18FY19: -$14.6M -$14.6M FY19FY20: -$9.7M -$9.7M FY20FY21: -$5.1M -$5.1M FY21FY22: -$11.9M -$11.9M FY22FY23: -$8.5M -$8.5M FY23FY24: -$4.3M -$4.3M FY24FY25: -$7.2M -$7.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$5.9M-$6.8M-$7.2M-$10.77-$4.7M
2024$6.9M-$4M-$4.3M-$20.88-$2.9M
2023$7.8M-$8.8M-$8.5M-$151.95-$3.8M
2022$7M-$9.9M-$11.9M-$272.34-$6.3M
2021$5.1M-$4.9M-$5.1M-$6.49-$9M
2020$2.8M-$5.2M-$9.7M-$20.78-$5M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where BKYI ranks in Technology

Revenue$5.9M
#616 of 751 in Technology · Bottom 18%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Technology

Latest SEC filings

What Bio Key International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 6, 2026
  2. October 6, 2026
  3. October 2, 2026
    Material agreement8-KBIO-key International fully resolved its secured promissory note by exchanging debt for 247,805 common shares.
  4. September 8, 2026
  5. September 8, 2026
  6. August 24, 2026
  7. August 14, 2026
  8. August 14, 2026
  9. August 13, 2026
  10. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 13% to $1.9M versus the same quarter last year; diluted EPS -$0.56 versus -$2.01.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 2, 2026. Insider transactions on SEC

Insider trades

What the people running Bio Key International Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
June 30, 2026 Lacous Mira KChief Technology Officer Received as pay 250 $3.83 $957.5 Form 4
June 30, 2026 Depasquale Michael WChief Executive Officer, Director Received as pay 250 $3.83 $957.5 Form 4
June 30, 2026 Sullivan James DavidChief Legal Officer Received as pay 250 $3.83 $957.5 Form 4
December 31, 2025 Depasquale Michael WChief Executive Officer, Director Received as pay 2,500 $0.46 $1.2K Form 4
December 31, 2025 Sullivan James DavidChief Legal Officer Received as pay 2,500 $0.46 $1.2K Form 4
December 31, 2025 Lacous Mira KChief Technology Officer Received as pay 2,500 $0.46 $1.2K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BKYI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Latest filings below 5%: Armistice Capital, LLC 4.99% (August 15, 2025); Streeterville Capital LLC 3.6% (June 10, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

3 insiders reported holding 24,840 shares in total, about $61.6K at the last price.

HolderSharesAs of
Depasquale Michael WChief Executive Officer, Director 10,778 June 30, 2026
Sullivan James DavidChief Legal Officer 9,986 June 30, 2026
Lacous Mira KChief Technology Officer 4,076 June 30, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BKYI

What does Bio Key International Inc do?

Bio Key International Inc is a company in the Technology sector, listed on NASDAQ as BKYI. Its shares trade on NASDAQ under the ticker BKYI.

What is Bio Key International Inc's net worth?

Bio Key International Inc has a market value (market cap) of $3.6M at the latest share price, and shareholders' equity of $4.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Bio Key International Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $6M on revenue of $6.7M.

How much revenue does Bio Key International Inc make?

Over the twelve months to June 30, 2026 Bio Key International Inc reported revenue of $6.7M. That is 3.1% less than a year earlier.

When did Bio Key International Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the additional proxy material from October 6, 2026.

Similar companies

Compare BKYI with

Compare BKYI with any company

Follow BKYI

Get an email when Bio Key International Inc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when BKYI files with the SEC.

Where the numbers come from

Financial figures are the values Bio Key International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.